BaylorScott&White

Dallas, Texas 95226

2 studies enrolling now · 11 studies all time

What they study most

Acute Decompensated Heart Failure, Acute Myeloid Leukemia, Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Liver Disease, Coronary Artery Calcification, Coronary Restenosis, Covid19, Diabetes Mellitus, Type 2, Dialysis; Complications, Lung Cancer, Multiple Myeloma, Multiple Myeloma in Relapse

Studies at this site

• Access Cannulation Trial II — Recruiting now
• Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) — Completed
• Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD) — Starting soon
• SELUTION SLR™ 014 In-stent Restenosis — Running, not enrolling
• The SHUNT-V Study for Varices — Completed
• A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients — Completed
• BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes — Status unconfirmed
• Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study — Status unconfirmed
• Retrospective Multi-Center Study to Compare Perioperative Outcomes for Robotic-assisted Lobectomy With Those Associated With VATS and Open Lobectomy for Lung Cancer — Completed
• Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma — Stopped early
• A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS — Completed